Literature DB >> 22472456

Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort study.

Rulin C Hechter1, Matthew Budoff, Howard N Hodis, Charles R Rinaldo, Frank J Jenkins, Lisa P Jacobson, Lawrence A Kingsley, Babafemi Taiwo, Wendy S Post, Joseph B Margolick, Roger Detels.   

Abstract

We assessed associations of herpes simplex virus types 1 and 2 (HSV-1 and -2), cytomegalovirus (CMV), and human herpesvirus 8 (HHV-8) infection with subclinical coronary atherosclerosis in 291 HIV-infected men in the Multicenter AIDS Cohort Study. Coronary artery calcium (CAC) was measured by non-contrast coronary CT imaging. Markers for herpesviruses infection were measured in frozen specimens collected 10-12 years prior to case identification. Multivariable logistic regression models and ordinal logistic regression models were performed. HSV-2 seropositivity was associated with coronary atherosclerosis (adjusted odds ratio [AOR]=4.12, 95% confidence interval [CI]=1.58-10.85) after adjustment for age, race/ethnicity, cardiovascular risk factors, and HIV infection related factors. Infection with a greater number of herpesviruses was associated with elevated CAC levels (AOR=1.58, 95% CI=1.06-2.36). Our findings suggest HSV-2 may be a risk factor for subclinical coronary atherosclerosis in HIV-infected men. Infection with multiple herpesviruses may contribute to the increased burden of atherosclerosis.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22472456      PMCID: PMC3392500          DOI: 10.1016/j.atherosclerosis.2012.03.002

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  14 in total

1.  Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma.

Authors:  L P Jacobson; F J Jenkins; G Springer; A Muñoz; K V Shah; J Phair; Z Zhang; H Armenian
Journal:  J Infect Dis       Date:  2000-05-26       Impact factor: 5.226

2.  Impact of infectious burden on progression of carotid atherosclerosis.

Authors:  Christine Espinola-Klein; Hans-Jürgen Rupprecht; Stefan Blankenberg; Christoph Bickel; Helmuth Kopp; Anja Victor; Gerd Hafner; Wilfried Prellwitz; Wolfgang Schlumberger; Jürgen Meyer
Journal:  Stroke       Date:  2002-11       Impact factor: 7.914

Review 3.  Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons.

Authors:  J A Rumberger; B H Brundage; D J Rader; G Kondos
Journal:  Mayo Clin Proc       Date:  1999-03       Impact factor: 7.616

4.  Coagulation initiated on herpesviruses.

Authors:  M R Sutherland; C M Raynor; H Leenknegt; J F Wright; E L Pryzdial
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

5.  Herpes simplex virus type 2 infection is a risk factor for hypertension.

Authors:  Yuhua Sun; Weidong Pei; Yongjian Wu; Zhicheng Jing; Jian Zhang; Guogan Wang
Journal:  Hypertens Res       Date:  2004-08       Impact factor: 3.872

6.  Impact of infectious burden on extent and long-term prognosis of atherosclerosis.

Authors:  Christine Espinola-Klein; Hans J Rupprecht; Stefan Blankenberg; Christoph Bickel; Helmuth Kopp; Gerd Rippin; Anja Victor; Gerd Hafner; Wolfgang Schlumberger; Jürgen Meyer
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

7.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

Authors:  R A Kaslow; D G Ostrow; R Detels; J P Phair; B F Polk; C R Rinaldo
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

8.  Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections.

Authors:  G Rezza; E T Lennette; M Giuliani; P Pezzotti; F Caprilli; P Monini; S Buttò; G Lodi; A Di Carlo; J A Levy; B Ensoli
Journal:  Int J Cancer       Date:  1998-07-29       Impact factor: 7.396

9.  Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture.

Authors:  R Renne; W Zhong; B Herndier; M McGrath; N Abbey; D Kedes; D Ganem
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

10.  Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins.

Authors:  Q J Wang; F J Jenkins; L P Jacobson; L A Kingsley; R D Day; Z W Zhang; Y X Meng; P E Pellett; K G Kousoulas; A Baghian; C R Rinaldo; P E Pellet
Journal:  Blood       Date:  2001-04-15       Impact factor: 22.113

View more
  12 in total

Review 1.  Cardiovascular disease and HIV infection.

Authors:  Virginia A Triant
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

Review 2.  Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy.

Authors:  Babafemi Taiwo; Luis Barcena; Randall Tressler
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

3.  Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.

Authors:  Sean Allen; Yu-Gang Liu; Evan Scott
Journal:  Regen Eng Transl Med       Date:  2016-03-03

Review 4.  Cardiovascular disease risk in an aging HIV population: not just a question of biology.

Authors:  Kaku So-Armah; Matthew S Freiberg
Journal:  Curr Opin HIV AIDS       Date:  2014-07       Impact factor: 4.283

5.  Synergistic enhancement of matrix metalloproteinase-9 expression and pro-inflammatory cytokines by influenza virus infection and oxidized-LDL treatment in human endothelial cells.

Authors:  Yun Wu; He Huang
Journal:  Exp Ther Med       Date:  2017-09-01       Impact factor: 2.447

Review 6.  Viral infection and atherosclerosis.

Authors:  Nima Hemmat; Amin Ebadi; Reza Badalzadeh; Mohammad Yousef Memar; Hossein Bannazadeh Baghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-05       Impact factor: 3.267

7.  Coinfection with human herpesvirus 8 is associated with persistent inflammation and immune activation in virologically suppressed HIV-infected patients.

Authors:  Mar Masiá; Catalina Robledano; Victoria Ortiz de la Tabla; Pedro Antequera; Blanca Lumbreras; Ildefonso Hernández; Félix Gutiérrez
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

Review 8.  Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus.

Authors:  Luis M Beltrán; Alfonso Rubio-Navarro; Juan Manuel Amaro-Villalobos; Jesús Egido; Juan García-Puig; Juan Antonio Moreno
Journal:  Vasc Health Risk Manag       Date:  2015-01-06

9.  Increased carotid intima-media thickness associated with antibody responses to varicella-zoster virus and cytomegalovirus in HIV-infected patients.

Authors:  Mar Masiá; Catalina Robledano; Victoria Ortiz de la Tabla; Pedro Antequera; Natividad López; Félix Gutiérrez
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

10.  HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution.

Authors:  Siew Hwei Yap; Noor Kamila Abdullah; Megan McStea; Kozo Takayama; Meng Li Chong; Elisa Crisci; Marie Larsson; Iskandar Azwa; Adeeba Kamarulzaman; Kok Hoong Leong; Yin Ling Woo; Reena Rajasuriar
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.